[1]
“The Role of Gliclazide on Galectin-3 Expression in Individuals with Left Ventricular Diastolic Dysfunction and Type 2 Diabetes Mellitus ”, mfm, vol. 35, no. 8, Aug. 2024, Accessed: Jan. 31, 2026. [Online]. Available: https://medicalforummonthly.com/index.php/mfm/article/view/4994